Induction of human sperm chemotaxis is an established phenomenon, though signaling systems physiologically involved have not been identified. Recently, it has been demonstrated that RANTES is present in the follicular fluid and that this molecule is a chemoactractant for human spermatozoa. However, the presence of β-chemokine receptors on human spermatozoa has never been reported. By cytometric, Western blotting and immunofluorescence analysis, we demonstrate the presence of CCR5 and CCR3 on ejaculated spermatozoa from healthy subjects. CCR5 was detected in the periacrosomal region of the sperm surface, whereas CCR3 was also present in the postacrosomal cap. Individual variability was observed on CCR5 and CCR3 positive sperm percentages. Presence of ∆32
cells, and are thereby recruited by the egg. The role of chemotaxis is the recruitment of a selective population of capacitated spermatozoa, ranging between 2 and 14% of the total sperm population (1) . A series of molecules present in the follicular fluid (FF) of several mammalian species, including humans, have been considered as possible sperm chemoattractants (2−4).
It has been recently reported that chemotactic cytokines, or chemokines, are involved in several human reproductive events, including sperm chemotaxis (5) . Chemokines are a large superfamily of structurally and functionally related molecules demonstrating chemotactic activity targeted at a specific leukocytes subset. They play an important role in many physiological and pathological processes and are classified in four subfamilies based on the relative position of their cysteine residues (CC, CXC, C, CXC3; refs 6, 7). Alfa-chemokines (CXCs) and β-chemokines (CCs) are the two main subfamilies of chemokines, whose specific receptors are classified as α and β chemokine receptors, respectively (8) . More recently, it has been demonstrated that human spermatozoa contain mRNA coding for the CC-chemokine receptors 1 and 5 (CCR1 and CCR5; refs 9, 10) that bind the β chemokine regulated upon activation of normal T-cells expressed and secreted (RANTES), and that RANTES has a chemotactic effect on human sperm (9) . The presence of CX3CR1 mRNA and protein, a receptor for an additional subgroup of chemokines, has also been demonstrated in sperm; it has consequently been suggested that fractalkine, the corresponding physiological ligand, plays a role in maintaining sperm motility and regulating sperm chemotaxis (11) . However, to our knowledge, the presence of β-chemokine receptor proteins on human spermatozoa has not been reported. In a research letter, we have communicated the presence of CCR5 on the human sperm surface, discussing the potential role of this receptor in the interaction between HIV-1 virions and human sperm (12) . CCR5 is indeed the main viral coreceptor used by macrophage-tropic viral strains, which are those most commonly involved in the sexual transmission of the HIV-1 infection (13, 14) .
Using a variety of techniques, we now report on the presence of both β-chemokine receptors 5 and 3 on the surface of ejaculated sperm cells from healthy subjects. Finally, we report different patterns of CCR5 and CCR3 expression in the spermatozoa of the subjects studied; in two of these subjects, the CCR5 gene expression pattern was associated with a haplotype bearing the ∆32 genetic deletion.
MATERIALS AND METHODS

Semen samples
Specimens from 33 normozoospermic healthy subjects attending the Laboratory of Seminology and Immunology of Reproduction of the Department of Medical Physiopathology, University of Rome "La Sapienza," were collected by masturbation after 3−5 days of sexual abstinence in sterile plastic jars. Semen was analyzed and processed within 2 h after ejaculation. Samples were allowed to liquefy for 30 min at 37°C and were then evaluated according to the WHO 1999 guidelines (15) . After removal of the seminal plasma by centrifugation, the sperm pellets were washed twice in 1× CMF (calcium magnesium-free phosphate buffered saline) and split in different aliquots. The study for CCR5 has been performed on all 33 subjects enrolled and on 8 of these for CCR3.
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Cytometric analysis
Aliquots of freshly isolated unfixed 5 × 10 5 sperm cells/tube from each of the subjects studied were incubated for 30 min on ice with 0.5 µg of mouse anti-human CCR5 or rat anti-human CCR3 (16) specific monoclonal antibodies (IgG2b clone 45549.111 and IgG2a clone 61828.111 by R&D Systems for CCR5 and CCR3, respectively) and, in control tubes, with 0.5 µg of corresponding IgG isotype antibodies (#M5534 by Sigma Aldrich and #553927 by BD Bioscience Pharmigen, respectively), as recommended by technical data sheets. The Ab-labeled sperm suspension was washed twice with 1× PBS/1% BSA, incubated with phycoerithryn conjugated secondary antibody (goat anti-mouse-PE and mouse anti-rat-PE, BD Bioscience Pharmigen, respectively, for CCR5 and CCR3 detection) and subsequently run through a flow cytometer (Epics XL Beckman Coulter, CA) where the dye was excited using an Argon 488nm excitation laser. The purity of the sperm cells gated was verified by analysis of the DNA content, measured using the DNA binding dye propidium iodine (PI; ref 17) . PBMC from healthy donors were used as positive controls.
Immunofluorescence analysis
Spermatozoa were fixed in cold acetone on microscope slides and air-dried. After being blocked with 1% BSA, the slides were incubated for 1 h on ice with 1:100 diluted anti-CCR5 or anti-CCR3 monoclonal antibodies. After being washed and incubated with secondary antibody (rat anti-mouse-FITC, Roche and donkey anti-rat-Cy3, Jackson ImmunoResearch, respectively), sperm cells were observed under a fluorescence microscope. In control samples, the reactions were performed using IgG isotype antibodies and by omitting the primary antibodies from the incubation mixture. PBMC from healthy donors were also used as positive control.
Extraction of total sperm proteins
Sperm proteins were extracted as described previously with minor modifications (18) . Briefly, pellets of 10 7 sperm cells were vigorously resuspended in 50 µl of lysis buffer containing 150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 1 mM Na 2 EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1mM β-glycerophosphate, 1 mM Na 3 VO 4 , 1 µg/ml leupeptin, 2% Triton-X, 1% SDS, 50 mM DTT, 5× protease inhibitors cocktail (#P8340, Sigma Aldrich), and stored at -20°C. After being thawed, samples were vortexed and sonicated on ice five times for 30 s each. After centrifugation, the supernatants were recovered and protein concentration tested on microplates using Bradford Dye (Bio-Rad protein assay) and read in a microplate reader (Bio-Rad).
Western blot analysis
Aliquots of 50 µg total sperm proteins were run on 10% acrylammide gel and then transferred onto a nitrocellulose membrane (Hybond C-Extra, Amersham Bioscience). Western blotting analysis for CCR5 and CCR3 was performed using 1:500 diluted antibodies (anti human-CCR5 clone 45549.111 by R&D Systems and #sc-8359 by Santa-Cruz Biotechnology and anti human-CCR3 #sc-7897 by Santa-Cruz Biotechnology). HRP-sheep anti-mouse IgG (#NA9310V by Amersham Bioscience) and HRP-rabbit anti-goat IgG (#61-1620 by Zymed) secondary antibodies (1:6000) and the ECL Plus chemiluminescent protein detection kit (Amersham Bioscience) were used. The α-tubulin protein was also detected (monoclonal antibody #T5168 by Sigma Aldrich) as internal control. Proteins from the PBMC of healthy donors were run on an adjacent lane as chemokine receptors positive control.
Genotyping of CCR5 gene for ∆32 deletion
Genotyping analysis for CCR5 gene was performed on 15 subjects. Sperm genomic DNA was extracted using the QIAamp DNA blood mini kit (Qiagen) according to the manufacturer's instructions, with minor modifications. Briefly, the sperm cell pellets (5×10 6 cells) were resuspended in 300 µl of 100 mM Tris-HCl pH 8.0, 10 mM EDTA, 500 mM NaCl, 1% SDS, 2% β-mercaptoethanol, and proteinase K (1.3 µg/µl) and incubated for four hours at 55°C. After 2 h, an aliquot of 20 µl of proteinase K (20 mg/ml) was further added. At the end of digestion, 400 µl AL buffer and 400 µl absolute ethanol were added and extraction was carried out according to the manufacturer's guide and the genomic DNA eluted in 100 µl sterile H 2 O. Quality and amount of extracted sperm genomic DNA were evaluated by electrophoresis. Aliquots of genomic samples were amplified with a primer pair specific for the CCR5 gene (forward 5′-aat ctt ctt cat cat cct cc-3′ and reverse 5′-tct ctg tca cct gca tag c-3′) that produce a 506 bp amplicon for the wild-type allele and a 474 bp amplicon for the ∆32 deletion allele (19) . Small aliquots of the first round of amplification were further amplified in seminested PCR reactions, with the forward primer paired used previously and an internal reverse primer (5′-tca cag ccc tgt gcc tct tct-3′) (20) , thereby obtaining a 358 bp amplicon for the wild-type allele and a 326 bp amplicon when the genetic ∆32 deletion was present. The absence of PCR inhibitors was verified using β-globin primers (GH20 5′-gaa gag cca agg aca ggt ac-3′; CP04 5′-caa ctt cat cca cgt tca cc-3′) as positive controls (21) . After initial denaturation at 94°C for 10 min, the amplification conditions for all primers used were: 94°C for 40 s, 55°C for 30 s and 72°C for 30 s, for 30 cycles. PCR products were analyzed by gel electrophoresis using 3% low melting agarose followed by ethidium bromide staining.
RESULTS
Cytometric analysis
The presence of CCR5 was studied in 33 subjects, and different expression patterns were found. In 3 subjects (9%), all the sperm cells expressed CCR5 (Fig. 1A) , whereas in 28 (85%) two sperm populations positive and negative, respectively, were observed with a percentage of CCR5 positive spermatozoa ranging from 25 to 75% (Fig. 1B-D) . Lastly, no sperm cells expressing CCR5 were detected in two subjects (6%; Fig. 1E ). The presence of CCR3 was studied in 8 of 33 subjects studied for CCR5 and always detected on the surface of sperm cells. In particular, five subjects had all spermatozoa strongly expressing CCR3 (Fig. 1F) , whereas in three subjects only 50% of the sperm population was CCR3 positive (Fig. 1G) . Purity of the sperm fractions analyzed was demonstrated by their haploid DNA content, measured using the DNA binding dye propidium iodine (Fig. 1H) . The fluorescence signal for the CCR5 and CCR3 antigens ranged from 5 to 50 times above their isotype controls (Fig. 1A-D, F, and G) , thus demonstrating that the β-chemokine receptor 5 and 3 are strongly expressed on the plasma membrane of ejaculated human spermatozoa. In all eight subjects studied for both chemokine receptors, CCR3 expression was higher than that observed for CCR5, both for the percentage of positive sperm cells and for the amount of chemokine receptors expressed at single cell level (data not shown).
Immunofluorescence localization
The cellular location of CCR5 and CCR3 was evaluated by immunofluorescence. A clear fluorescent signal was observed on the surface of the sperm head for both CCR5 and CCR3 (Fig.  2) . CCR5 staining homogeneously decorated the periacrosomal region ( Fig. 2A and C) , whereas staining for CCR3 had a granular appearance and a distribution either diffused to all the sperm head or localized in the peri or postacrosomal region (Fig. 2E and G) . Immunofluorescence microscopy observations confirmed the results obtained by flow cytometric analysis concerning the amount of positive cells. Positive and negative controls for both chemokine receptors detection were always, and successfully, performed.
Western blot analysis
To further investigate the presence of CCR5 and CCR3 in ejaculated spermatozoa, Western blotting analysis was performed. A specific immunoreactive band at the expected molecular weight and similar to that of the positive control (PBMC) was found for both chemokine receptor 5 and 3 ( Fig. 3A and B) . In the two subjects with all CCR5 negative spermatozoa at cytometric analysis, none CCR5 immunoreactive band was detected (Fig. 3A) .
Genotyping of CCR5 gene for the ∆32 deletion
To verify whether the variability of CCR5 expression observed on ejaculated spermatozoa could be related to sperm haplotypes mutated for CCR5 gene, we investigated the possible presence of the ∆32 deletion in the CCR5 gene, in the subjects with two populations of spermatozoa, CCR5 positive and negative. This mutation corresponds to the second extracellular loop, and it is known to be responsible for the lack of CCR5 receptor expression on the cell membrane. Indeed, individuals who have inherited the ∆32 defective CCR5 allele encode a severely truncated protein that fails to reach the cell surface (22) . Genotyping analysis for the ∆32 deletion was performed to investigate the lack of CCR5 expression. Fifteen subjects, 2 with all CCR5 positive sperm and 13 with no more than 50% CCR5-positive sperm, were analyzed using two specific primer sets spanning the region of the chemokine receptor 5 gene containing the possible deletion. As expected, in the subject with all CCR5-positive sperm, amplification yielded a single band corresponding to the wild-type alleles (Fig. 4) . The presence of the ∆32 deletion in heterozygosis was observed in 2 of the 13 subjects that had spermatozoa both positive and negative for CCR5. This subject displayed, together with the expected band of 506 bp (produced by amplifying the wild-type allele), a shorter amplification band of 474 bp (corresponding to the deleted allele) after PCR, and 358 bp and 326 bp bands after seminested-PCR (Fig. 4) .
DISCUSSION
CCR3 and CCR5 are two of major receptors of the CC subclasse of the chemokine family. CCR3 is expressed on eosinophils, basophils, mast cells, and a subset of human TH2-like T lymphocytes (23) . CCR3 is the only known receptor for eotaxin and eotaxin 2, but also recognizes other chemokines such as RANTES, macrophage inflammatory protein-1α (MIP-1 α), and monocyte chemotactic proteins-2, -3, and -4 (MCP-2, -3, -4) (24), which bind to additional receptors. CCR5, in response to normal β-chemokine ligands, is involved in the chemotaxis of leukocytes toward
Page 5 of 15 (page number not for citation purposes)
site of inflammation. Presence of CCR5 has also been described on a variety of epithelial cells, vascular smooth muscle cells, and fibroblasts (25) .
Chemokines are involved in several human reproductive events, including sperm chemotaxis (5); however, β-chemokine receptor on human sperm has never been reported. Our data demonstrate, for the first time, the presence of both CCR3 and CCR5 on ejaculated spermatozoa. Cytometric analysis, performed on fresh nonpermeabilized cells, demonstrated that both chemokine receptors were strongly expressed on the sperm surface of healthy normozoospermic subjects. Immunofluorescence experiments located CCR5 on the periacrosomal region of the plasma membrane, whereas CCR3 had a diffused distribution on the sperm head. Western blotting analysis confirmed the presence of both receptor proteins of the expected molecular weights. Our data are in agreement with the recent demonstration, by RT-PCR, that CCR5 mRNAs are present in ejaculated human spermatozoa (9, 10) , which represents the first evidence for the presence of CCR3 on the surface of human spermatozoa. We suggest that previous failure (26) to demonstrate significant CCR5 levels on human spermatozoa by flow cytometry, using FITC-conjugated monoclonal antibody, may have been due to technical problems. We found that the use of PE fluorochrome, as opposed to FITC, increased detection sensitivity, and that clone 45549.111 antibody was the most suitable anti-human CCR5 antibody as regards both sensitivity and specificity, even in immunofluorescence and Western blotting.
Cytometric analysis of CCR5 demonstrated that CCR5 expression in the positive sperm ranged between 5−50 times above its isotype control, thus suggesting that CCR5 expression on the sperm membrane is finely regulated during spermiogenesis. In addition, the percentage of chemokine receptor positive sperm varied in the cohort studied: in the majority of the subjects (28 out of 33), 25−75% of the sperm were CCR5 positive, whereas in the remainder the sperm was either all positive (3 cases) or all negative (2 cases). These different cytometric profiles were confirmed by immunofluorescence.
Cell surface expression levels of chemokine receptors may vary, being determined by the rates of receptor endocytosis and recycling (27) . Only half of the sperm population has been found positive for CX3CR1 (11) , and individual differences on the expression of CCR3 have been described in dendritic cells (28) . We tested whether CCR5 expression in the sperm plasma membrane of a subpopulation of spermatozoa could be related to sperm haplotypes mutated for the CCR5 gene. Segregation of the alleles that occurs in haploid germ cells may produce, in individuals who are heterozygous for a specific gene, two genetically different sperm cell populations that can be revealed as two different expression profiles by cytometric analysis (29) . Product sharing via intercellular bridges conjoining differentiating germ cells is thought to guarantee gametic equality despite haploid gene activity in mammalian spermiogenesis. However, it has been reported that haploid-expressed membrane proteins and sperm antigens cannot diffuse through the cytoplasmic bridges, thus resulting in functionally different sperm cells in each male (29) (30) (31) . Since CCR5 anddeletion was detected, together with the wild-type allele (∆32 +/-), in 2 of the 13 subjects displaying sperm that were half negative and half positive for CCR5 in cytometric analysis. The ∆32 deletion was not detected in two subjects with all CCR5-positive sperm cells (∆32 +/+ ). These genotyping data demonstrate that expression of CCR5 on the membrane of half sperm population may be due to heterozygotic mutation in the relative gene. Unfortunately, we could not perform genotyping analysis in the subjects whose sperm cells did not express the CCR5 receptor, as revealed by cytometric analysis, Western blotting and immunofluorescence.
Data on the presence of CCR3 refer to 8 of the 33 normozoospermic subjects studied for CCR5. CCR3 was observed in the sperm head with a localization more diffused than that observed for CCR5. Five subjects had all spermatozoa strongly expressing CCR3, and in three subjects, half of the sperm population was positive. In all eight subjects studied, CCR3 expression was higher than that observed for CCR5 both as percentage of cells expressing the receptor and as amount of receptor present in each cell. The two different CCR3 expression patterns observed need to be further investigated to verify their possible genetic origin, although, to our knowledge, mutations responsible for lack of CCR3 expression have not been reported.
Sperm chemotaxis consists in the regulation of sperm movement direction that occurs at the time of fertilization, once the capacitated sperm is in close proximity to the egg (1, 2) . The induction of chemotaxis in human sperm by FF in vitro appears to be well established, and a series of molecules present in the FF of several mammalian species, including humans, have been considered as possible sperm chemoattractants (2-4), though the chemoattractant(s) in FF has not yet been identify. Recently, it has been reported that chemokines are involved in several human reproductive events (5) and that sperm cells are capable of migrating by following a chemoattractant gradient of soluble β-chemokine factors such as RANTES, which has been found in a variety of genital tract fluids (36) and in the FF (9) . Based on these observations and on the presence of a stable CCR5 mRNA isoform in human spermatozoa, it has been proposed that the signaling system RANTES and its receptors play a role in sperm chemotaxis.
Here, we demonstrate the presence of the CCR5 and CCR3 on the human sperm plasma membrane, thus confirming the specificity of this molecular mechanism. Preliminary cytometric evidence, obtained in same subjects studied for both CCR3 and CCR5, demonstrated that also CCR1 is present on the human sperm, although in smaller percentage of cells (data not shown). It is conceivable that more than one chemokine receptor is involved in the chemotactic sperm recruitment induced by molecule(s) present in the follicular fluid (9, 37) , and, on the other hand, it is known that β-chemokines such as RANTES are promiscuous ligands able to bind to more than one receptor (38) . The functional role of the chemokines-chemokine receptors system in sperm chemotaxis will be evaluated by inhibition and competition experiments for each of the ligands present in FF and of the receptors identified in the human sperm. Chemokine receptor 3 is described to facilitate infection by a subset of primary HIV-1 isolates as well as to promote efficient infection of microglia and CNS by the virus (19, 39) . Chemokine receptor 5 is considered to be the main coreceptor for cell entry used by macrophage-tropic HIV-1 viral strains, which are those most commonly involved in the sexual transmission of HIV-1 infection (22) . Individuals bearing the ∆32 −/− defective CCR5 gene are resistant to HIV infection in spite of multiple sexual viral exposures (22, 40) . Heterozygous individuals for this mutation appear to exhibit a slower progression of the disease and a lower blood viral load (41) .
Although it is known that semen may contain both cell-free virions (42) and HIV-1 infected leukocytes (43) and that viruses adhering to leukocyte and sperm cell surfaces are also carried to the sexual partner (44) , the mechanisms of viral adhesion to sperm cells remain poorly understood. We have recently proposed that the presence of CCR5 on the sperm membrane, alone or in association with other molecules, may allow HIV-1 interaction with spermatozoa (12) . The demonstration of CCR3 expression on the sperm head surface provides additional evidence that β-chemokine receptors may be responsible for HIV-1 adhesion to the sperm surface, shedding light on how spermatozoa act as cellular carriers of virions during the sexual transmission of HIV-1 infection (45). ). Lanes 6 and 7: heterozygous subject for CCR5 ∆32 mutation (∆32 +/-). A double band corresponding to the mutated allele is detected after PCR (lane7) and also after seminested PCR (lane 6).
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